Cargando…

Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways

Gut microbiota dysbiosis is related to cancer development and progression. Our previous study showed that Ruminococcus was more abundant in CRPC (Castration-resistant prostate cancer) than HSPC (Hormone-sensitive prostate cancer) individuals. Here, we determined the potential mechanism of microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yufei, Yang, Chen, Zhang, Zheyu, Jiang, Haowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249243/ https://www.ncbi.nlm.nih.gov/pubmed/34221998 http://dx.doi.org/10.3389/fonc.2021.679712

Ejemplares similares

Gut Microbiota Dysbiosis in the Development and Progression of Gastric Cancer
por: Miao, Yingying, et al.
Publicado: (2022)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production
por: Han, Chao, et al.
Publicado: (2020)

LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1
por: Ji, Weidan, et al.
Publicado: (2021)

Impact of DNA damage repair alterations on prostate cancer progression and metastasis
por: Lukashchuk, Natalia, et al.
Publicado: (2023)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
por: Zha, Cheng, et al.
Publicado: (2023)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization
por: Liu, Yufei, et al.
Publicado: (2023)

Dysbiosis of Oral Microbiota During Oral Squamous Cell Carcinoma Development
por: Sarkar, Purandar, et al.
Publicado: (2021)

Impact of intestinal dysbiosis on breast cancer metastasis and progression
por: Zhang, Jin, et al.
Publicado: (2022)

The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development
por: Genua, Flavia, et al.
Publicado: (2021)

Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
por: Yang, Ning, et al.
Publicado: (2023)

Gut dysbiosis is associated with acceleration of lupus nephritis
por: Valiente, Giancarlo R., et al.
Publicado: (2022)

Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response
por: Zhang, Nan, et al.
Publicado: (2021)

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
por: Sun, Yan, et al.
Publicado: (2023)

Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
por: Huang, Yinhua, et al.
Publicado: (2021)

Gut microbiota and immunity relevance in eubiosis and dysbiosis
por: Al-Rashidi, Hanan E.
Publicado: (2022)

The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
por: Wang, Jing, et al.
Publicado: (2019)

Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
por: Yan, Fengna, et al.
Publicado: (2023)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
por: Zhang, Qianpeng, et al.
Publicado: (2016)

Gut Microbiota Dysbiosis and Increased NLRP3 Levels in Patients with Pregnancy-Induced Hypertension
por: Wu, Jingjing, et al.
Publicado: (2023)

Periodontitis may induce gut microbiota dysbiosis via salivary microbiota
por: Bao, Jun, et al.
Publicado: (2022)

Dysbiosis of gut microbiota in promoting the development of colorectal cancer
por: Zou, Shaomin, et al.
Publicado: (2018)

Dysbiosis characteristics of gut microbiota in cerebral infarction patients
por: Li, Hao, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis and COVID-19: Possible Links
por: Aktas, Busra
Publicado: (2022)

Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction
por: Han, Ying, et al.
Publicado: (2021)

Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
por: Belvoncikova, Paulina, et al.
Publicado: (2022)

Corrigendum: The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_69o5rcu2v22knvev5n0kl66s5p